KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - AccuredReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueGross ProfitLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - AccuredReceivables - NetReceivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

Twist Bioscience (TWST) Receivables - Other (2018 - 2026)

Twist Bioscience has reported Receivables - Other over the past 9 years, most recently at $112000.0 for Q1 2026.

  • Quarterly Receivables - Other fell 92.41% to $112000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $112000.0 through Mar 2026, down 92.41% year-over-year, with the annual reading at $290000.0 for FY2025, 85.72% down from the prior year.
  • Receivables - Other was $112000.0 for Q1 2026 at Twist Bioscience, down from $12.3 million in the prior quarter.
  • Over five years, Receivables - Other peaked at $12.3 million in Q4 2025 and troughed at $112000.0 in Q1 2026.
  • The 5-year median for Receivables - Other is $2.6 million (2024), against an average of $3.1 million.
  • Year-over-year, Receivables - Other plummeted 96.57% in 2022 and then surged 1150.0% in 2023.
  • A 5-year view of Receivables - Other shows it stood at $200000.0 in 2022, then surged by 1150.0% to $2.5 million in 2023, then fell by 26.52% to $1.8 million in 2024, then surged by 569.52% to $12.3 million in 2025, then plummeted by 99.09% to $112000.0 in 2026.
  • Per Business Quant, the three most recent readings for TWST's Receivables - Other are $112000.0 (Q1 2026), $12.3 million (Q4 2025), and $290000.0 (Q3 2025).